April 4, 2024

The American College of Radiology® (ACR®) recently partnered with the North American Spine Society (NASS) and five other specialty societies to send a comment letter to UnitedHealthcare regarding the insurer’s negative coverage policy for basivertebral nerve ablation (BVNA).

The insurer now holds the position that “there is insufficient evidence to establish the safety and efficacy of intraosseous radiofrequency ablation of the basivertebral nerve for treating low back pain.” In the letter, the medical societies stress this position led to inappropriate denial of care for patients and told the insurer there is well-established scientific evidence that supports BVNA as a safe and effective procedure. ACR opposes any coverage policy that denies care where evidence is established and accepted by the medical profession.

To date, all the Medicare Administrative Contractors (MACs) and more than 20 other insurance carriers extend coverage and approve the appropriate use of BVNA. ACR continues to work with commercial payers and MACs to advocate for accurate medical policies that reflect clinical practice and do not delay care for patients. The medical societies hope UnitedHealthcare will consider revising its policy to reflect the evidence and provide coverage accordingly.

The College will continue to monitor any changes to this policy and notify members as needed.

If you have questions or would like more information about spinal pain coverage policies and our collaborative activities, contact Alicia Blakey, ACR Principal Economic Policy Analyst.


Related ACR News

  • CMS Releases 2026 Medicare Physician Fee Schedule Final Rule

    CMS released the 2026 MPFS final rule Oct. 31. ACR prepared an initial summary about impact on imaging.

    Read more
  • Massachusetts Legislature Updates Prior Authorization Bill

    Massachusetts HB 4616 aims to streamline prior authorization, boost transparency, and study its impact on care access and costs.

    Read more
  • ACR Responds to RFI on AI Regulatory Reform

    ACR urged the White House to enhance AI oversight and payment policies to support safe, effective, and reimbursable clinical AI use.

    Read more